These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1979175

  • 1. Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs.
    Allard P, Eriksson K, Ross SB, Marcusson JO.
    Psychopharmacology (Berl); 1990; 102(3):291-4. PubMed ID: 1979175
    [Abstract] [Full Text] [Related]

  • 2. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
    Allard PO, Eriksson K, Ross SB, Marcusson JO.
    Neuropsychobiology; 1990; 23(4):177-81. PubMed ID: 2130286
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of cocaine on dopamine transporter receptors depends on routes of chronic cocaine administration.
    Hitri A, Little KY, Ellinwood EH.
    Neuropsychopharmacology; 1996 Mar; 14(3):205-10. PubMed ID: 8866704
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
    Richfield EK.
    Brain Res; 1991 Feb 01; 540(1-2):1-13. PubMed ID: 1829013
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors.
    Ogren SO, Rosén L, Fuxe K.
    Neuroscience; 1994 Jul 01; 61(2):269-83. PubMed ID: 7969908
    [Abstract] [Full Text] [Related]

  • 9. Subchronic treatment of rats with remoxipride fails to modify sigma binding sites in the brain.
    Ericson H, Ross SB.
    Eur J Pharmacol; 1992 Jun 05; 226(2):157-61. PubMed ID: 1353452
    [Abstract] [Full Text] [Related]

  • 10. Alterations in the dopaminergic receptor system after chronic administration of cocaine.
    Alburges ME, Narang N, Wamsley JK.
    Synapse; 1993 Aug 05; 14(4):314-23. PubMed ID: 8161369
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H, Högberg T, Halldin C, Bengtsson S, Wedel I.
    Eur J Pharmacol; 1991 Aug 16; 201(1):1-10. PubMed ID: 1686586
    [Abstract] [Full Text] [Related]

  • 13. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 16; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O, Biggio G.
    Brain Res; 1990 Nov 12; 533(1):53-9. PubMed ID: 1982234
    [Abstract] [Full Text] [Related]

  • 18. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
    LaHoste GJ, Marshall JF.
    Neuroscience; 1991 Nov 12; 41(2-3):473-81. PubMed ID: 1678501
    [Abstract] [Full Text] [Related]

  • 19. Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: III. Dopamine uptake.
    Lim DK, Yu ZJ, Hoskins B, Rockhold RW, Ho IK.
    Neurochem Res; 1990 Jun 12; 15(6):629-34. PubMed ID: 2215854
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.